{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T18:16:45Z","timestamp":1790619405367,"version":"4.1.0"},"reference-count":73,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T00:00:00Z","timestamp":1509494400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"International Research Support Initiative Program (IRSIP)"},{"name":"Helsinki Institute of Life Science"},{"DOI":"10.13039\/501100006306","name":"Sigrid Jus\u00e9lius Foundation","doi-asserted-by":"crossref","award":["4704580"],"award-info":[{"award-number":["4704580"]}],"id":[{"id":"10.13039\/501100006306","id-type":"DOI","asserted-by":"crossref"}]},{"name":"European Research Council under the European Union\u2019s Seventh Framework Programme","award":["310892"],"award-info":[{"award-number":["310892"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Pharmaceutics"],"published-print":{"date-parts":[[2017,11]]},"DOI":"10.1016\/j.ijpharm.2017.09.061","type":"journal-article","created":{"date-parts":[[2017,9,28]],"date-time":"2017-09-28T01:46:20Z","timestamp":1506563180000},"page":"156-168","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":132,"title":["Development and optimization of methotrexate-loaded lipid-polymer hybrid nanoparticles for controlled drug delivery applications"],"prefix":"10.1016","volume":"533","author":[{"given":"Nayab","family":"Tahir","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asadullah","family":"Madni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vimalkumar","family":"Balasubramanian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mubashar","family":"Rehman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra","family":"Correia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prince Muhammad","family":"Kashif","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ermei","family":"M\u00e4kil\u00e4","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jarno","family":"Salonen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H\u00e9lder A.","family":"Santos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijpharm.2017.09.061_bib0005","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1007\/s00280-012-2062-0","article-title":"A review of therapeutic challenges and achievements of methotrexate delivery systems for treatment of cancer and rheumatoid arthritis","volume":"71","author":"Abolmaali","year":"2013","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.ijpharm.2017.09.061_bib0010","doi-asserted-by":"crossref","first-page":"239","DOI":"10.3109\/02652048.2013.834991","article-title":"Characterisation, cytotoxicity and apoptosis studies of methotrexate-loaded PLGA and PLGA-PEG nanoparticles","volume":"31","author":"Afshari","year":"2014","journal-title":"J. Microencapsulation"},{"key":"10.1016\/j.ijpharm.2017.09.061_bib0015","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.addr.2012.09.037","article-title":"Liposomal drug delivery systems: from concept to clinical applications","volume":"65","author":"Allen","year":"2013","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ijpharm.2017.09.061_bib0020","doi-asserted-by":"crossref","first-page":"17077","DOI":"10.3390\/ijms150917077","article-title":"Triethanolamine stabilization of methotrexate-\u03b2-cyclodextrin interactions in ternary complexes","volume":"15","author":"Barbosa","year":"2014","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ijpharm.2017.09.061_bib0025","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1016\/j.biomaterials.2008.12.013","article-title":"PLGA\u2013lecithin\u2013PEG core\u2013shell nanoparticles for controlled drug delivery","volume":"30","author":"Chan","year":"2009","journal-title":"Biomaterials"},{"key":"10.1016\/j.ijpharm.2017.09.061_bib0030","doi-asserted-by":"crossref","first-page":"3133","DOI":"10.1007\/s10853-016-0602-4","article-title":"The fabrication and characterization of a PLGA nanoparticle\u2013Pheroid\u00ae combined drug delivery system","volume":"52","author":"Chelopo","year":"2017","journal-title":"J. Mater. Sci."},{"key":"10.1016\/j.ijpharm.2017.09.061_bib0035","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.colsurfb.2011.02.033","article-title":"Factors affecting drug encapsulation and stability of lipid\u2013polymer hybrid nanoparticles","volume":"85","author":"Cheow","year":"2011","journal-title":"Colloids Surf. B: Biointerfaces"},{"key":"10.1016\/j.ijpharm.2017.09.061_bib0040","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0928-0987(01)00095-1","article-title":"Modeling and comparison of dissolution profiles","volume":"13","author":"Costa","year":"2001","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ijpharm.2017.09.061_bib0045","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1007\/s10973-012-2580-3","article-title":"Structural and thermal properties of spray-dried methotrexate-loaded biodegradable microparticles","volume":"112","author":"de Oliveira","year":"2013","journal-title":"J. Therm. Anal. Calorim."},{"key":"10.1016\/j.ijpharm.2017.09.061_bib0050","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1002\/jbm.a.30865","article-title":"Controlled release of bioactive doxorubicin from microspheres embedded within gelatin scaffolds","volume":"79","author":"DeFail","year":"2006","journal-title":"J. Biomed. Mater. Res. A"},{"key":"10.1016\/j.ijpharm.2017.09.061_bib0055","doi-asserted-by":"crossref","first-page":"14411","DOI":"10.1039\/C6NR04091H","article-title":"Ultra-small lipid\u2013polymer hybrid nanoparticles for tumor-penetrating drug delivery","volume":"8","author":"Dehaini","year":"2016","journal-title":"Nanoscale"},{"key":"10.1016\/j.ijpharm.2017.09.061_bib0060","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1080\/03639045.2017.1304957","article-title":"Lipid nanoparticles of zaleplon for improved oral delivery by Box\u2013Behnken design: optimization, in vitro and in vivo evaluation","volume":"43","author":"Dudhipala","year":"2017","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/j.ijpharm.2017.09.061_bib0065","first-page":"25","article-title":"Application of response surface methodology and artificial neural network for analysis of p-chlorophenol biosorption by dried activated sludge","volume":"10","author":"Fanaie","year":"2016","journal-title":"J. Appl. Chem. Res."},{"key":"10.1016\/j.ijpharm.2017.09.061_bib0070","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.ijpharm.2015.07.013","article-title":"Optimization of nanostructured lipid carriers loaded with methotrexate: a tool for inflammatory and cancer therapy","volume":"492","author":"Ferreira","year":"2015","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2017.09.061_bib0075","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40199-014-0087-0","article-title":"Formulation and optimization of itraconazole polymeric lipid hybrid nanoparticles (Lipomer) using box behnken design","volume":"23","author":"Gajra","year":"2015","journal-title":"DARU J. Pharm. Sci."},{"key":"10.1016\/j.ijpharm.2017.09.061_bib0080","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s40199-014-0087-0","article-title":"Formulation and optimization of itraconazole polymeric lipid hybrid nanoparticles (Lipomer) using box behnken design","volume":"23","author":"Gajra","year":"2015","journal-title":"DARU J. Pharm. Sci."},{"key":"10.1016\/j.ijpharm.2017.09.061_bib0085","doi-asserted-by":"crossref","first-page":"747","DOI":"10.3109\/03639045.2015.1093496","article-title":"Formulation, optimization and characterization of cationic polymeric nanoparticles of mast cell stabilizing agent using the Box\u2013Behnken experimental design","volume":"42","author":"Gajra","year":"2016","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/j.ijpharm.2017.09.061_bib0090","doi-asserted-by":"crossref","first-page":"62989","DOI":"10.1039\/C5RA12459J","article-title":"Development and characterization of single step self-assembled lipid polymer hybrid nanoparticles for effective delivery of methotrexate","volume":"5","author":"Garg","year":"2015","journal-title":"RSC Adv."},{"key":"10.1016\/j.ijpharm.2017.09.061_bib0095","doi-asserted-by":"crossref","DOI":"10.1021\/acs.molpharmaceut.6b01148","article-title":"Functionalized lipid\u2013polymer hybrid nanoparticles mediated codelivery of methotrexate and aceclofenac: a synergistic effect in breast cancer with improved pharmacokinetics attributes","author":"Garg","year":"2017","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ijpharm.2017.09.061_bib0100","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.3892\/ol.2014.2840","article-title":"Transferrin-conjugated doxorubicin-loaded lipid-coated nanoparticles for the targeting and therapy of lung cancer","volume":"9","author":"Guo","year":"2015","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.ijpharm.2017.09.061_bib0105","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/j.ijbiomac.2016.06.014","article-title":"Methotrexate loading in chitosan nanoparticles at a novel pH: Response surface modeling, optimization and characterization","volume":"91","author":"Hashad","year":"2016","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.ijpharm.2017.09.061_bib0110","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1002\/adfm.201404122","article-title":"On\u2010chip self\u2010assembly of a smart hybrid nanocomposite for antitumoral applications","volume":"25","author":"Herranz\u2010Blanco","year":"2015","journal-title":"Adv. Funct. Mater."},{"key":"10.1016\/j.ijpharm.2017.09.061_bib0115","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1111\/cas.12737","article-title":"Novel nanosystem to enhance the antitumor activity of lapatinib in breast cancer treatment: therapeutic efficacy evaluation","volume":"106","author":"Huo","year":"2015","journal-title":"Cancer Sci."},{"key":"10.1016\/j.ijpharm.2017.09.061_bib0120","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.actbio.2015.06.027","article-title":"Surface engineered polymeric nanocarriers mediate the delivery of transferrin\u2013methotrexate conjugates for an improved understanding of brain cancer","volume":"24","author":"Jain","year":"2015","journal-title":"Acta Biomater."},{"key":"10.1016\/j.ijpharm.2017.09.061_bib0125","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.jcis.2008.02.031","article-title":"Preparation of PLLA\/PLGA microparticles using solution enhanced dispersion by supercritical fluids (SEDS)","volume":"322","author":"Kang","year":"2008","journal-title":"J. Colloid Interface Sci."},{"key":"10.1016\/j.ijpharm.2017.09.061_bib0130","first-page":"1","article-title":"Development of eudragit RS 100 microparticles loaded with ropinirole: optimization and in vitro evaluation studies","author":"Kashif","year":"2016","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.ijpharm.2017.09.061_bib0135","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.jhazmat.2009.07.025","article-title":"Application of Box\u2013Behnken design in the optimization of a magnetic nanoparticle procedure for zinc determination in analytical samples by inductively coupled plasma optical emission spectrometry","volume":"172","author":"Khajeh","year":"2009","journal-title":"J. Hazard. Mater."},{"key":"10.1016\/j.ijpharm.2017.09.061_bib0140","article-title":"ATR-FTIR based pre and post formulation compatibility studies for the design of niosomal drug delivery system containing nonionic amphiphiles and chondroprotective drug","volume":"37","author":"Khan","year":"2015","journal-title":"J. Chem. Soc. Pak."},{"key":"10.1016\/j.ijpharm.2017.09.061_bib0145","first-page":"1","article-title":"Ultrasonic processing technique as a green preparation approach for diacerein-Loaded niosomes","author":"Khan","year":"2016","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.ijpharm.2017.09.061_bib0150","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1021\/ja808137c","article-title":"Entrapment of hydrophobic drugs in nanoparticle monolayers with efficient release into cancer cells","volume":"131","author":"Kim","year":"2009","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.ijpharm.2017.09.061_bib0155","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.ijpharm.2017.01.021","article-title":"In vivo pharmacokinetic studies and intracellular delivery of methotrexate by means of glycine-tethered PLGA-based polymeric micelles","volume":"519","author":"Kumar","year":"2017","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2017.09.061_bib0160","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.ijpharm.2010.05.008","article-title":"Nanoparticles of lipid monolayer shell and biodegradable polymer core for controlled release of paclitaxel: effects of surfactants on particles size, characteristics and in vitro performance","volume":"395","author":"Liu","year":"2010","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2017.09.061_bib0165","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1590\/S1516-93322006000400007","article-title":"Thermoanalytical study of praziquantel-loaded PLGA nanoparticles","volume":"42","author":"Mainardes","year":"2006","journal-title":"Revista Brasileira de Ci\u00eancias Farmac\u00eauticas"},{"key":"10.1016\/j.ijpharm.2017.09.061_bib0170","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.3109\/21691401.2015.1042108","article-title":"Application of Box\u2013Behnken design to prepare gentamicin-loaded calcium carbonate nanoparticles","volume":"44","author":"Maleki Dizaj","year":"2016","journal-title":"Artif. Cells Nanomed. Biotechnol."},{"key":"10.1016\/j.ijpharm.2017.09.061_bib0175","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.ejps.2015.10.021","article-title":"Development and in vitro evaluation of core\u2013shell type lipid\u2013polymer hybrid nanoparticles for the delivery of erlotinib in non-small cell lung cancer","volume":"81","author":"Mandal","year":"2016","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ijpharm.2017.09.061_bib0180","doi-asserted-by":"crossref","first-page":"31996","DOI":"10.3402\/nano.v7.31996","article-title":"Synthesis of protein-coated biocompatible methotrexate-loaded PLA-PEG-PLA nanoparticles for breast cancer treatment","volume":"7","author":"Massadeh","year":"2016","journal-title":"Nano Rev. Exp."},{"key":"10.1016\/j.ijpharm.2017.09.061_bib0185","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1590\/S0100-40422011000600004","article-title":"Encapsulation of naproxen in nanostructured system: structural characterization and in vitro release studies","volume":"34","author":"Mello","year":"2011","journal-title":"Qu\u00edmica Nova"},{"key":"10.1016\/j.ijpharm.2017.09.061_bib0190","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1590\/S0100-40422011000600004","article-title":"Encapsulation of naproxen in nanostructured system: structural characterization and in vitro release studies","volume":"34","author":"Mello","year":"2011","journal-title":"Qu\u00edmica Nova"},{"key":"10.1016\/j.ijpharm.2017.09.061_bib0195","doi-asserted-by":"crossref","first-page":"635","DOI":"10.3109\/10837450.2015.1116565","article-title":"Preparation and in vitro evaluation of 5-fluorouracil-loaded PCL nanoparticles for colon cancer treatment","volume":"22","author":"\u00d6zt\u00fcrk","year":"2017","journal-title":"Pharm. Dev. Technol."},{"key":"10.1016\/j.ijpharm.2017.09.061_bib0200","first-page":"2101","article-title":"Novel surface modified polymer\u2013lipid hybrid nanoparticles as intranasal carriers for ropinirole hydrochloride: in vitro, ex vivo and in vivo pharmacodynamic evaluation","volume":"24","author":"Pardeshi","year":"2013","journal-title":"J. Mater. Sci."},{"key":"10.1016\/j.ijpharm.2017.09.061_bib0205","doi-asserted-by":"crossref","first-page":"76491","DOI":"10.1039\/C5RA12732G","article-title":"Rationally developed core\u2013shell polymeric-lipid hybrid nanoparticles as a delivery vehicle for cromolyn sodium: implications of lipid envelop on in vitro and in vivo behaviour of nanoparticles upon oral administration","volume":"5","author":"Patel","year":"2015","journal-title":"RSC Adv."},{"key":"10.1016\/j.ijpharm.2017.09.061_bib0210","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1038\/nnano.2007.387","article-title":"Nanocarriers as an emerging platform for cancer therapy","volume":"2","author":"Peer","year":"2007","journal-title":"Nat. Nano"},{"key":"10.1016\/j.ijpharm.2017.09.061_bib0215","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1166\/jnn.2016.11669","article-title":"Application of response surface methodology for the technological improvement of solid lipid nanoparticles","volume":"16","author":"Pizzol","year":"2016","journal-title":"J. Nanosci. Nanotechnol."},{"key":"10.1016\/j.ijpharm.2017.09.061_bib0220","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/j.carbpol.2013.11.009","article-title":"Layer-by-layer coated lipid\u2013polymer hybrid nanoparticles designed for use in anticancer drug delivery","volume":"102","author":"Ramasamy","year":"2014","journal-title":"Carbohydr. Polym."},{"key":"10.1016\/j.ijpharm.2017.09.061_bib0225","doi-asserted-by":"crossref","first-page":"131","DOI":"10.3109\/03639045.2013.850710","article-title":"Design, optimization and evaluation of poly-\u03b5-caprolactone (PCL) based polymeric nanoparticles for oral delivery of lopinavir","volume":"41","author":"Ravi","year":"2015","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/j.ijpharm.2017.09.061_bib0230","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.ejps.2016.08.030","article-title":"Nanostructured lipid carriers as robust systems for topical lidocaine-prilocaine release in dentistry","volume":"93","author":"Ribeiro","year":"2016","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ijpharm.2017.09.061_bib0235","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0168-3659(02)00127-X","article-title":"Residual polyvinyl alcohol associated with poly (D, L-lactide-co-glycolide) nanoparticles affects their physical properties and cellular uptake","volume":"82","author":"Sahoo","year":"2002","journal-title":"J. Controlled Release"},{"key":"10.1016\/j.ijpharm.2017.09.061_bib0240","first-page":"467","article-title":"Targeted therapy using nanotechnology: focus on cancer","volume":"9","author":"Sanna","year":"2014","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.ijpharm.2017.09.061_bib0245","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.jddst.2017.02.012","article-title":"Design of lipid-polymer hybrid nanoparticles for therapy of BPH: Part I: Formulation optimization using a design of experiment approach","volume":"39","author":"Sengel-Turk","year":"2017","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"10.1016\/j.ijpharm.2017.09.061_bib0250","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.colsurfb.2008.10.020","article-title":"Methotrexate-incorporated polymeric nanoparticles of methoxy poly(ethylene glycol)-grafted chitosan","volume":"69","author":"Seo","year":"2009","journal-title":"Colloids Surf. B: Biointerfaces"},{"key":"10.1016\/j.ijpharm.2017.09.061_bib0255","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1166\/jbn.2013.1474","article-title":"Folic acid conjugated guar gum nanoparticles for targeting methotrexate to colon cancer","volume":"9","author":"Sharma","year":"2013","journal-title":"J. Biomed. Nanotechnol."},{"key":"10.1016\/j.ijpharm.2017.09.061_bib0260","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1166\/jbn.2015.1965","article-title":"Arginine-glycine-aspartic acid-modified lipid-polymer hybrid nanoparticles for docetaxel delivery in glioblastoma multiforme","volume":"11","author":"Shi","year":"2015","journal-title":"J. Biomed. Nanotechnol."},{"key":"10.1016\/j.ijpharm.2017.09.061_bib0265","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1080\/03639045.2016.1232726","article-title":"Cuboidal lipid polymer nanoparticles of rosuvastatin for oral delivery","volume":"43","author":"Suares","year":"2017","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/j.ijpharm.2017.09.061_bib0270","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.ajps.2017.03.002","article-title":"Feasibility of drug delivery to the eye's posterior segment by topical instillation of PLGA nanoparticles","volume":"12","author":"Tahara","year":"2017","journal-title":"Asian J. Pharm. Sci."},{"key":"10.1016\/j.ijpharm.2017.09.061_bib0275","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.ijpharm.2012.04.033","article-title":"The in vivo antitumor activity of LHRH targeted methotrexate\u2013human serum albumin nanoparticles in 4T1 tumor-bearing Balb\/c mice","volume":"431","author":"Taheri","year":"2012","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2017.09.061_bib0280","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.onano.2016.03.002","article-title":"Optimization and in-vivo evaluation of isradipine nanoparticles using Box-Behnken design surface response methodology","volume":"1","author":"Venugopal","year":"2016","journal-title":"OpenNano"},{"key":"10.1016\/j.ijpharm.2017.09.061_bib0285","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1007\/s11095-014-1515-z","volume":"32","author":"Wakaskar","year":"2015","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ijpharm.2017.09.061_bib0290","first-page":"e77","article-title":"Types of Nanocarriers\u2013Formulation method and applications","volume":"9","author":"Wakaskar","year":"2017","journal-title":"J. Bioequiv. Availab."},{"key":"10.1016\/j.ijpharm.2017.09.061_bib0295","first-page":"1","article-title":"Brief overview of nanoparticulate therapy in cancer","author":"Wakaskar","year":"2017","journal-title":"J. Drug Target."},{"key":"10.1016\/j.ijpharm.2017.09.061_bib0300","first-page":"1","article-title":"General overview of lipid-polymer hybrid nanoparticles, dendrimers, micelles, liposomes, spongosomes and cubosomes","author":"Wakaskar","year":"2017","journal-title":"J. Drug Target."},{"key":"10.1016\/j.ijpharm.2017.09.061_bib0305","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1016\/j.carbpol.2011.06.080","article-title":"Self-assembled nanoparticles of methotrexate conjugated O-carboxymethyl chitosan: preparation, characterization and drug release behavior in vitro","volume":"86","author":"Wang","year":"2011","journal-title":"Carbohydr. Polym."},{"key":"10.1016\/j.ijpharm.2017.09.061_bib0310","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.actbio.2015.01.021","article-title":"Dual-drug delivery by porous silicon nanoparticles for improved cellular uptake, sustained release, and combination therapy","volume":"16","author":"Wang","year":"2015","journal-title":"Acta Biomater."},{"key":"10.1016\/j.ijpharm.2017.09.061_bib0315","doi-asserted-by":"crossref","first-page":"3380","DOI":"10.1002\/adfm.201403921","article-title":"Structure\u2010invertible nanoparticles for triggered Co\u2010delivery of nucleic acids and hydrophobic drugs for combination cancer therapy","volume":"25","author":"Wang","year":"2015","journal-title":"Adv. Funct. Mater."},{"key":"10.1016\/j.ijpharm.2017.09.061_bib0320","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.ejpb.2009.06.002","article-title":"Design for optimization of nanoparticles integrating biomaterials for orally dosed insulin","volume":"73","author":"Woitiski","year":"2009","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ijpharm.2017.09.061_bib0325","first-page":"1","article-title":"Targeted nanomedicine for prostate cancer therapy: docetaxel and curcumin co-encapsulated lipid\u2013polymer hybrid nanoparticles for the enhanced anti-tumor activity in vitro and in vivo","author":"Yan","year":"2015","journal-title":"Drug Deliv."},{"key":"10.1016\/j.ijpharm.2017.09.061_bib0330","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1124\/pr.115.012070","article-title":"Lipid-based drug delivery systems in cancer therapy: what is available and what is yet to come","volume":"68","author":"Yingchoncharoen","year":"2016","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.ijpharm.2017.09.061_bib0335","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1021\/nn800275r","article-title":"Self-assembled lipid- polymer hybrid nanoparticles: a robust drug delivery platform","volume":"2","author":"Zhang","year":"2008","journal-title":"ACS Nano"},{"key":"10.1016\/j.ijpharm.2017.09.061_bib0340","doi-asserted-by":"crossref","first-page":"9912","DOI":"10.1021\/acsnano.5b05792","article-title":"Microfluidic synthesis of hybrid nanoparticles with controlled lipid layers: understanding flexibility-regulated cell\u2013nanoparticle interaction","volume":"9","author":"Zhang","year":"2015","journal-title":"ACS Nano"},{"key":"10.1016\/j.ijpharm.2017.09.061_bib0345","first-page":"2101","article-title":"Folate-modified lipid\u2013polymer hybrid nanoparticles for targeted paclitaxel delivery","volume":"10","author":"Zhang","year":"2015","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.ijpharm.2017.09.061_bib0350","doi-asserted-by":"crossref","first-page":"10034","DOI":"10.1021\/acsami.7b02196","article-title":"Receptor-mediated surface charge inversion platform based on porous silicon nanoparticles for efficient cancer cell recognition and combination therapy","volume":"9","author":"Zhang","year":"2017","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.ijpharm.2017.09.061_bib0355","article-title":"Design of nanocarriers for nanoscale drug delivery to enhance cancer treatment using hybrid polymer and lipid building blocks","author":"Zhang","year":"2017","journal-title":"Nanoscale"},{"key":"10.1016\/j.ijpharm.2017.09.061_bib0360","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.biomaterials.2014.12.028","article-title":"Co-delivery of HIF1 (siRNA and gemcitabine via biocompatible lipid-polymer hybrid nanoparticles for effective treatment of pancreatic cancer","volume":"46","author":"Zhao","year":"2015","journal-title":"Biomaterials"},{"key":"10.1016\/j.ijpharm.2017.09.061_bib0365","doi-asserted-by":"crossref","first-page":"4792","DOI":"10.1166\/jnn.2015.9604","article-title":"Lipid-polymer nanoparticles for folate-receptor targeting delivery of doxorubicin","volume":"15","author":"Zheng","year":"2015","journal-title":"J. Nanosci. Nanotechnol."}],"container-title":["International Journal of Pharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378517317309274?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378517317309274?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,10,18]],"date-time":"2020-10-18T06:42:00Z","timestamp":1603003320000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378517317309274"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11]]},"references-count":73,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,11]]}},"alternative-id":["S0378517317309274"],"URL":"https:\/\/doi.org\/10.1016\/j.ijpharm.2017.09.061","relation":{},"ISSN":["0378-5173"],"issn-type":[{"value":"0378-5173","type":"print"}],"subject":[],"published":{"date-parts":[[2017,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development and optimization of methotrexate-loaded lipid-polymer hybrid nanoparticles for controlled drug delivery applications","name":"articletitle","label":"Article Title"},{"value":"International Journal of Pharmaceutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijpharm.2017.09.061","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}